Bradley Merrill Thompson Quoted in “Will FDA Regulate Your Mobile Medical App?”Medical Device and Diagnostic Industry August 6, 2014
Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was quoted in an article titled "Will FDA Regulate Your Mobile Medical App?"
Following is an excerpt:
Mobile medical applications are one of the hottest health trends going. More than half a billion smartphone users are expected to be using mobile medical apps next year, and that number will climb to more than 1.7 billion by 2018, according to a report from Research2Guidance.
It's no surprise, then, that the medical device industry is becoming increasingly interested in developing these apps. But FDA, too, has taken notice. In September 2013, the agency issued its Mobile Medical Applications Guidance for Industry and Staff to explain how it would approach regulation of this emerging field.
MD+DI editorial advisory board member Bradley Merrill Thompson, a member of law firm Epstein Becker & Green and head of the firm's Connected Health Initiative, has been following FDA's progress on mobile apps regulation. Together with Worrell, aproduct design, development, and strategy firm that collaborates with medical devicecompanies and entrepreneurs, he developed the following infographic guide to help developers quickly and easily determine if their mobile medical apps can slip through the regulatory cracks or if they must face FDA scrutiny.